William Rust is the founder of Seraxis. Seraxis has raised $40M in total funding. Latest round: Series C. Backed by Eli Lilly. Based in Germantown, MD.
William Rust is the Founder, CEO, and Director of the Board at Seraxis, a company dedicated to developing organoid replacement therapy for type 1 diabetes. Seraxis aims to replace damaged pancreatic cells with lab-grown stem cells, eliminating the need for insulin injections. Rust's work includes developing proprietary stem cell lines and pancreas organoids, protected by multiple patents. Under his strategic direction, Seraxis has grown through several rounds of financing.
Full founder directory · Investor directory · Company funding database · Fundraising library